We are live on ! Find out more
PDLI

PDL BioPharma, Inc.
PDLI

Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

223 hedge funds and large institutions have $1.75B invested in PDL BioPharma, Inc. in 2014 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 81 increasing their positions, 78 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% more repeat investments, than reductions

Existing positions increased: 81 | Existing positions reduced: 78

1% more capital invested

Capital invested by funds: $1.72B → $1.75B (+$24.3M)

3% less funds holding

Funds holding: 231 → 223 (-8)

19% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 26

55% less call options, than puts

Call options by funds: $2.02M | Put options by funds: $4.49M

Holders
223
Holders Change
-8
Holders Change %
-3.46%
% of All Funds
5.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
81
Reduced
78
Closed
26
Calls
$2.02M
Puts
$4.49M
Net Calls
-$2.47M
Net Calls Change
-$496K

Top Buyers

Rank Fund Capital Flow
1
First Trust Advisors
First Trust Advisors
Illinois
+$60.1M
2
LCP
Lombardia Capital Partners
California
+$10.8M
3
Robeco Institutional Asset Management
Robeco Institutional Asset Management
Netherlands
+$8.36M
4
Invesco
Invesco
Georgia
+$8.08M
5
Allianz Asset Management
Allianz Asset Management
Germany
+$7.9M

Top Sellers

Rank Fund Capital Flow
1
QI
QS Investors
New York
-$17.6M
2
Renaissance Technologies
Renaissance Technologies
New York
-$15.6M
3
NI
Numeric Investors
Massachusetts
-$7.22M
4
Wells Fargo
Wells Fargo
California
-$6.59M
5
Morgan Stanley
Morgan Stanley
New York
-$6.37M
Name Holding Trade Value Shares
Change 		Change in
Stake
WCBA
201
Weaver C. Barksdale & Associates
Tennessee
$6K +$3.24K +409 +124%
CFA
202
Carroll Financial Associates
North Carolina
$5K – – –
PR
203
Payden & Rygel
California
$5K – – –
FANJ
204
Financial Architects (New Jersey)
New Jersey
$4K – – –
LWCFA
205
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$4K – – –
MWP
206
MYCIO Wealth Partners
Pennsylvania
$4K – – –
Envestnet Asset Management
207
Envestnet Asset Management
Illinois
$3K – – –
BPBT
208
Boston Private Bank & Trust
Massachusetts
$2K – – –
WA
209
Winfield Associates
Ohio
$2K – – –
Northwestern Mutual Wealth Management
210
Northwestern Mutual Wealth Management
Wisconsin
$2K +$2.22K +280 New
FCCM
211
First City Capital Management
Georgia
$1.85K – – –
PIA
212
Piedmont Investment Advisors
North Carolina
$1.47K – – –
PG
213
PEAK6 Group
Illinois
$1K -$104K -13,190 -99%
ClearBridge Investments
214
ClearBridge Investments
New York
$1K – – –
WTC
215
WhitTier Trust Company
Nevada
$1K – – –
FHA
216
First Horizon Advisors
Tennessee
$1K +$24 +3 +2%
Manulife (Manufacturers Life Insurance)
217
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$786 -$8.53K -1,078 -1%
NG
218
NatWest Group
United Kingdom
$545 +$272K +34,420 +95%
BPM
219
Bowling Portfolio Management
Ohio
$99 +$102K +12,831 New
BRWA
220
B. Riley Wealth Advisors
Florida
$24 +$24.5K +3,094 New
SAM
221
Shell Asset Management
Netherlands
– -$1.81M -242,091 Closed
CCMH
222
Cornerstone Capital Management Holdings
New York
– -$1.33M -178,750 Closed
American Century Companies
223
American Century Companies
Missouri
– -$1.14M -152,745 Closed
LA
224
Linden Advisors
New York
– -$704K -94,198 Closed
GLA
225
Great Lakes Advisors
Illinois
– -$702K -94,038 Closed
6 7 8
9
10

PDLI Hedge Fund Activity: Q4 2014 in Review

223 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in PDL BioPharma, Inc. (PDLI) for Q4 2014, worth a combined $1.75B — up 1.4% from $1.72B a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of PDLI and 21 opened new positions — a net loss of 5 holders — while 78 trimmed existing stakes and 81 added.

The largest buyer was First Trust Advisors, adding an estimated $60.1M. The largest seller was QS Investors, cutting an estimated $17.6M.

  • 223 institutional investors held PDL BioPharma, Inc. (PDLI) as of Q4 2014, down from 231 in Q3 2014.
  • Funds reported $1.75B of PDL BioPharma, Inc. stock for Q4 2014, up 1.4% quarter-over-quarter.
  • 21 funds opened new PDL BioPharma, Inc. positions in Q4 2014 and 26 closed out, a net change of -5 holders.
  • The largest PDL BioPharma, Inc. buyer in Q4 2014 was First Trust Advisors, an estimated $60.1M added.
  • The largest PDL BioPharma, Inc. seller in Q4 2014 was QS Investors, an estimated $17.6M sold.

Based on aggregated 13F filings for Q4 2014.